Results 271 to 280 of about 216,446 (286)
Some of the next articles are maybe not open access.
Mapping the EORTC QLQ-C30 and QLQ H&N35 to the EQ-5D-5L and SF-6D for papillary thyroid carcinoma
Quality of Life Research, 2023Deyu Huang +4 more
semanticscholar +1 more source
Reliability, validity, and minimally important differences of the SF-6D in systemic sclerosis
Quality of Life Research, 2007To evaluate the reliability and validity and estimate the minimally important difference (MID) for the SF-6D in patients with systemic sclerosis (SSc). Subjects We used data from two clinical studies to analyze the SF-6D in patients with SSc: Study 1 was a cross-sectional observational study (N = 107) designed to assess three direct preference measures-
Dinesh, Khanna +9 more
openaire +2 more sources
Outcome Assessment for Cost-Utility Evaluations: SF-6D vs. EQ-5D
2010What was formerly known as medicine has now become health care, an amalgam of several disciplines, including health economics. The role of health economics is fairly straightforward, namely to facilitate priority-setting under the objective of maximizing population health.
Søgaard, Rikke +2 more
openaire +2 more sources
Mapping analysis to predict SF-6D utilities from health outcomes in people with focal epilepsy
European Journal of Health Economics, 2022I. Flint +7 more
semanticscholar +1 more source
Evaluating the psychometric properties of the EQ-5D-5L and SF-6D among patients with haemophilia
European Journal of Health Economics, 2021R. Xu +9 more
semanticscholar +1 more source
EQ-5D and SF-6D health utility scores in patients with spinal and bulbar muscular atrophy
European Journal of Health Economics, 2022R. Xu, Ming Lu, Shuyang Zhang, D. Dong
semanticscholar +1 more source

